Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 33

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

An International Survey of Health Care Services Available to Patients With Tourette Syndrome

Bhikram, Tracy, Elmaghraby, Rana, Abi-Jaoude, Elia, Sandor, Paul · 2021 · Frontiers in Psychiatry

Abstract

Objective: Tourette syndrome (TS) is a neuropsychiatric disorder that is highly associated with several comorbidities. Given the complex and multifaceted nature of TS, the condition is managed by a wide variety of practitioners in different disciplines. The goal of this study was to investigate health service delivery and care practices by clinicians who see TS patients across different geographic settings internationally. Methods: A comprehensive questionnaire was developed to assess clinical care resources for patients with TS and was sent to clinicians in Canada (CA), the United States (US), Europe (EU), and the United Kingdom (UK). Responses were compared quantitatively between geographic regions. Results: The majority of respondents, regardless of region, reported that fewer than 40% of their case-load are patients with tics. The accessibility of TS services varied among regions, as indicated by differences in wait times, telemedicine offerings, comorbidity management and the availability of behavioral therapies. First-line pharmacotherapy preferences varied among physicians in different geographical regions with CA respondents preferring alpha-2-adrenergic agonists and respondents from the UK and EU preferring dopamine receptor antagonists. Discussion: The results suggest that there is a scarcity of specialized TS clinics, potentially making access to services challenging, especially for patients newly diagnosed with TS. Differences in regional pharmacotherapeutic preferences are reflected in various published treatment guidelines in EU and North America. The lack of dedicated specialists and telemedicine availability, coupled with differences in comorbidity management, highlight the need for interprofessional care and holistic management to improve health care delivery to patients with TS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2021.621874

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. Knight, 2012, Prevalence of tic disorders: a systematic review and meta-analysis, Pediatr Neurol., 47, 77, 10.1016/j.pediatrneurol.2012.05.002 · DOI · Paper page
  2. Scharf, 2015, Population prevalence of Tourette syndrome: a systematic review and meta-analysis, Mov Disord., 30, 221, 10.1002/mds.26089 · DOI · Paper page
  3. Pringsheim, 2009, Understanding disability in Tourette syndrome, Dev Med Child Neurol., 51, 468, 10.1111/j.1469-8749.2008.03168.x · DOI
  4. Wilhelm, 2012, Randomized trial of behavior therapy for adults with Tourette syndrome, Arch Gen Psychiatry., 69, 795, 10.1001/archgenpsychiatry.2011.1528 · DOI · Paper page
  5. Scahill, 2013, Current controversies on the role of behavior therapy in Tourette syndrome, Mov Disord., 28, 1179, 10.1002/mds.25488 · DOI · Paper page
  6. Sandor, 2003, Pharmacological management of tics in patients with TS, J Psychosom Res., 55, 41, 10.1016/S0022-3999(03)00060-6 · DOI
  7. Pringsheim, 2012, Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy, Can J Psychiatry., 57, 133, 10.1177/070674371205700302 · DOI · Paper page
  8. Eddy, 2011, Quality of life in young people with Tourette syndrome: a controlled study, J Neurol., 258, 291, 10.1007/s00415-010-5754-6 · DOI · Paper page
  9. Conelea, 2011, Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey, Child Psychiatry Hum Dev., 42, 219, 10.1007/s10578-010-0211-4 · DOI · Paper page
  10. Elstner, 2001, Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome, Acta Psychiatr Scand., 103, 52, 10.1111/j.1600-0447.2001.00147.x · doi:10.1111/j.1600-0447.2001.00147.x · Paper page
  11. Storch, 2007, Quality of life in youth with Tourette's syndrome and chronic tic disorder, J Clin Child Adolesc Psychol., 36, 217, 10.1080/15374410701279545 · DOI · Paper page
  12. Aldred, 2015, Tourette syndrome and socioeconomic status, Neurol Sci., 36, 1643, 10.1007/s10072-015-2223-0 · DOI
  13. Cavanna, 2013, Health-related quality of life in Gilles de la Tourette syndrome: a decade of research, Behav Neurol., 27, 83, 10.1155/2013/732038 · DOI
  14. Bitsko, 2014, A National Profile of Tourette Syndrome, 2011–2012, J Dev Behav Pediatr., 35, 317, 10.1097/DBP.0000000000000065 · DOI
  15. Bitsko, 2013, Health Care Needs of Children With Tourette Syndrome, J Child Neurol., 28, 1626, 10.1177/0883073812465121 · DOI
  16. Freeman, 2000, An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries, Dev Med Child Neurol., 42, 436, 10.1017/S0012162200000839 · DOI · Paper page
  17. Efron, 2020, Assessment and management of tic disorders and Tourette syndrome by Australian paediatricians, J Paediatr Child Health., 56, 136, 10.1111/jpc.14541 · DOI
  18. Bachmann, 2015, Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany, Eur Child Adolesc Psychiatry., 24, 199, 10.1007/s00787-014-0563-6 · DOI
  19. Carulla-Roig, 2018, Pharmacoepidemiology of Tourette and Chronic Tic Disorders in Sweden 2005–2013, J Child Adolesc Psychopharmacol., 28, 637, 10.1089/cap.2017.0169 · DOI
  20. Hamamoto, 2019, Expert consensus on pharmacotherapy for tic disorders in Japan, Brain Dev., 41, 501, 10.1016/j.braindev.2019.02.003 · DOI
  21. Munce, 2017, Health and Community-Based Services for Individuals with Neurological Conditions, Can J Neurol Sci., 44, 670, 10.1017/cjn.2017.207 · DOI
  22. Wolicki, 2019, Children with Tourette Syndrome in the United States: Parent-Reported Diagnosis, Co-Occurring Disorders, Severity, and Influence of Activities on Tics, J Dev Behav Pediatr., 40, 407, 10.1097/DBP.0000000000000667 · DOI
  23. Rivera-Navarro, 2009, The diagnosis of Tourette's Syndrome: communication and impact, Clin Child Psychol Psychiatry., 14, 13, 10.1177/1359104508100127 · DOI
  24. Cuenca, 2015, Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study, BMC Psychiatry., 15, 46, 10.1186/s12888-015-0430-0 · DOI
  25. Marcks, 2004, What do those who know, know? Investigating providers' knowledge about Tourette's Syndrome and its treatment, Cognit Behav Pract., 11, 298, 10.1016/S1077-7229(04)80044-0 · DOI
  26. Woods, 2007, Barriers to Dissemination: Exploring the Criticisms of Behavior Therapy for Tics, 14, 279, 10.1111/j.1468-2850.2007.00088.x · DOI · Paper page
  27. Kim, 2003, The American Academy of Child and Adolescent Psychiatry Task Force on, Workforce Needs. Child and adolescent psychiatry workforce: a critical shortage and national challenge, Academic Psychiatry., 27, 277, 10.1176/appi.ap.27.4.277 · DOI · Paper page
  28. Leckman, 1998, Course of tic severity in Tourette syndrome: the first two decades, Pediatrics., 102, 14, 10.1542/peds.102.1.14 · DOI · Paper page
  29. Rizzo, 2012, Long term clinical course of Tourette syndrome, Brain Dev., 34, 667, 10.1016/j.braindev.2011.11.006 · DOI
  30. Verdellen, European clinical guidelines for Tourette Syndrome and other tic disorders. Part III: behavioural and psychosocial interventions, Eur Child Adolesc Psychiatry., 20, 197, 10.1007/s00787-011-0167-3 · DOI · Paper page
  31. Steeves, 2012, Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation, Can J Psychiatry., 57, 144, 10.1177/070674371205700303 · DOI · Paper page
  32. Cath, 2011, European clinical guidelines for Tourette Syndrome and other tic disorders. Part I: assessment, Eur Child Adolesc Psychiatry., 20, 155, 10.1007/s00787-011-0164-6 · DOI · Paper page
  33. Conelea, Treating tourette together: an agenda for patient-centered research focused on comprehensive behavior therapy for tics, PsyArXiv [Preprint]., 10.31234/osf.io/qhb2z · DOI
  34. Olfson, 2011, Patterns and correlates of tic disorder diagnoses in privately and publicly insured youth, J Am Acad Child Adolesc Psychiatry., 50, 119, 10.1016/j.jaac.2010.11.009 · DOI
  35. Smith, 2017, Outpatient Treatment of Tic Disorders Among Children and Adults, Mov Disord Clin Pract., 4, 559, 10.1002/mdc3.12472 · DOI
  36. Himle, 2012, A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders, Behav Res Ther., 50, 565, 10.1016/j.brat.2012.05.009 · DOI · Paper page
  37. Cothros, 2019, Prescriptions for alpha agonists and antipsychotics in children and youth with tic disorders: a pharmacoepidemiologic study, Tremor Other Hyperkinet Mov., 9, 10.5334/tohm.459 · DOI
  38. Farag, 2015, Serial pharmacological prescribing practices for tic management in Tourette syndrome, Hum Psychopharmacol Clin Exp., 30, 435, 10.1002/hup.2495 · DOI
  39. Rickards, 2012, Treatment practices in Tourette syndrome: the European perspective, Eur J Paediatr Neurol., 16, 361, 10.1016/j.ejpn.2011.12.001 · DOI
  40. Osland, 2018, Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders, Cochrane Database Syst Rev., 6, CD007990, 10.1002/14651858.CD007990.pub3 · DOI
  41. Desarkar, 2006, Sertraline caused tics in a child with obsessive-compulsive disorder, J Pediatr Neurol., 4, 283, 10.1055/s-0035-1557335 · DOI
  42. Abi-Jaoude, 2009, Tourette syndrome: a model of integration. Handbook of Integrative Clinical Psychology, Psychiatry and Behavioral Medicine: Perspectives, Practices and Research, 549
  43. Reeves, 2009, Multimodal treatments versus pharmacotherapy alone in children with psychiatric disorders: implications of access, effectiveness, and contextual treatment, Paediatr Drugs., 11, 165, 10.2165/00148581-200911030-00002 · DOI
  44. Ganos, 2016, Tics in the pediatric population: pragmatic management, Mov Disord Clin Pract., 1, 145, 10.1002/mdc3.12043 · DOI

Cited by

See all 33

Metadata

Authors
Bhikram, T., Elmaghraby, R., Abi-Jaoude, E., & Sandor, P.
Venue
Frontiers in Psychiatry
Published
2021-02-26
Volume
12
ISSN
1664-0640
Cited by
33
References
5
Funders
Toronto General and Western Hospital Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.